204 related articles for article (PubMed ID: 35115618)
1. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
2. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
3. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
4. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.
Fournane S; Charbonnier S; Chapelle A; Kieffer B; Orfanoudakis G; Travé G; Masson M; Nominé Y
J Mol Recognit; 2011; 24(4):511-23. PubMed ID: 20842623
[TBL] [Abstract][Full Text] [Related]
5. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
6. Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells.
Garibay-Cerdenares OL; Sánchez-Meza LV; Encarnación-Guevara S; Hernández-Ortíz M; Martínez-Batallar G; Torres-Rojas FI; Mendoza-Catalán MÁ; Moral-Hernández OD; Leyva-Vázquez MA; Illades-Aguiar B
Cancer Genomics Proteomics; 2021; 18(3):273-283. PubMed ID: 33893080
[TBL] [Abstract][Full Text] [Related]
7. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.
Nicolaides L; Davy C; Raj K; Kranjec C; Banks L; Doorbar J
Virology; 2011 Jun; 414(2):137-45. PubMed ID: 21489588
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity.
Sarabia-Vega V; Banks L
J Gen Virol; 2020 Sep; 101(9):954-962. PubMed ID: 30810519
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.
Webb Strickland S; Brimer N; Lyons C; Vande Pol SB
Virology; 2018 Mar; 516():127-138. PubMed ID: 29346075
[TBL] [Abstract][Full Text] [Related]
11. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
[TBL] [Abstract][Full Text] [Related]
12. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.
Zehbe I; Richard C; DeCarlo CA; Shai A; Lambert PF; Lichtig H; Tommasino M; Sherman L
Virology; 2009 Jan; 383(1):69-77. PubMed ID: 18986660
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.
Thomas M; Laura R; Hepner K; Guccione E; Sawyers C; Lasky L; Banks L
Oncogene; 2002 Aug; 21(33):5088-96. PubMed ID: 12140759
[TBL] [Abstract][Full Text] [Related]
15. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.
Glaunsinger BA; Lee SS; Thomas M; Banks L; Javier R
Oncogene; 2000 Nov; 19(46):5270-80. PubMed ID: 11077444
[TBL] [Abstract][Full Text] [Related]
16. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.
Ainsworth J; Thomas M; Banks L; Coutlee F; Matlashewski G
Virol J; 2008 Jun; 5():67. PubMed ID: 18518978
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B
J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796
[TBL] [Abstract][Full Text] [Related]
18. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
19. MAGI-1 PDZ2 Domain Blockade Averts Adenovirus Infection via Enhanced Proteolysis of the Apical Coxsackievirus and Adenovirus Receptor.
Alghamri MS; Sharma P; Williamson TL; Readler JM; Yan R; Rider SD; Hostetler HA; Cool DR; Kolawole AO; Excoffon KJDA
J Virol; 2021 Jun; 95(13):e0004621. PubMed ID: 33762416
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants.
Rodríguez-Ruiz HA; Garibay-Cerdenares OL; Illades-Aguiar B; Montaño S; Jiang X; Leyva-Vázquez MA
BMC Mol Cell Biol; 2019 Aug; 20(1):35. PubMed ID: 31426742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
